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Abstract
Objective: Clinical significance determines whether an intervention makes a real difference in the everyday life of a client.
One of the most recommended approaches for conducting group-level analyses of clinical significance is to evaluate whether
the treated clinical group is equivalent to a normal comparison group (normative comparisons). The purpose of this study
was to demonstrate the analytical and practical power of assessing clinical significance using normative comparisons that are
robust to violations of normality and homogeneity of variance assumptions. Method: Six datasets were gleaned from
published intervention studies for depression. Results: We found that normative comparisons using a robust Schuirmann-
Yuen test determined equivalency for 11% fewer clinical samples compared to original normative comparisons that use a
Schuirmann test of equivalence. Conclusions: We recommend that researchers conducting normative comparisons utilize
the Schuirmann-Yuen procedure as it provides the most reliable method available for determining if a treated clinical group
is equivalent to a normative comparison group.
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When a clinician attempts to determine which ther-
apy is appropriate for a particular client, he or she is
likely to consider the clinical significance of that
therapeutic intervention. Clinical significance, the
measure of whether an intervention makes a real
difference in the everyday life of the clients or others
with whom the clients interact, represents an import-
ant advance in the treatment, prevention, and rehab-
ilitation of mental health concerns (Kazdin, 1999).
Its introduction by Jacobson, Follette, and Reven-
storf (1984) was regarded as an important develop-
ment in methodology (Lambert, Shapiro, & Bergin,
1986) and it has since become an expected statistic
in published intervention studies by many journal
editors (Bauer, Lambert, & Nielsen, 2004). There
have been a number of different statistical approaches
proposed to assess clinical significance, each with a
different representation of what constitutes a “real
difference” in a therapeutic outcome.
At the root of these different representations is
the amount or degree of change clients experience
from pre- to post-treatment. Prior to the introduc-
tion of clinical significance, this client change was
assessed using only traditional analyses and findings
that were statistically significant represented an
efficacious intervention (Moleiro & Beutler, 2009).
There has been, however, a growing recognition
among clinical researchers that reliance on tradi-
tional inferential statistical analyses to evaluate
treatment efficacy is problematic (Kazdin, 1999;
Kendall & Sheldrick, 2000; Kraemer et al., 2003;
Lunnen & Ogles, 1998) and that statistically signi-
ficant differences between groups do not necessarily
indicate practical, meaningful, or clinically signific-
ant differences between groups, nor for individuals
within the groups (Ogles, Lunnen, & Bonesteel,
2001). Therefore, when investigators infer the
efficacy of certain interventions by referencing
statistically significant differences found between
two group means following treatment, the amelior-
ative effect of the intervention is not established and
may not be genuine. Thus, the purpose of the
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current study is to provide a review of normative
comparisons, i.e., group-level measures of clinical
significance that focus on the equivalence of treated
and normal comparison populations, and specific-
ally to highlight an improved normative comparison
procedure that is less susceptible to problems due
to non-normality and unequal group variances. We
begin with a brief introduction to clinical signific-
ance before introducing normative comparison
procedures and demonstrating/comparing these
procedures with real data from intervention studies
for depression.
Determining Clinical Significance
The first method proposed for assessing clinical
significance (Jacobson et al., 1984), with slight
modifications by Jacobson and Truax (1991), sug-
gested a two-step criterion to assess clinically signi-
ficant change (also see Jacobson, Roberts, Berns, &.
McGlinchey, 1999, for a discussion of potential
modifications and alternatives to the method). First,
a cutoff point is established that the client has to
cross at the time of the post-treatment assessment to
be classified as changed to a clinically significant
degree. Next, a reliable change index (RCI) is
calculated to determine how much change has
occurred during the course of the therapy and
whether this change is reliable and not due to
measurement error.
Although the Jacobson and Truax (1991) method
may be the most popular method for assessing clinical
significance (Ogles et al., 2001), it is not the only way
of conceptualizing the quantification of clinical
significance. The Jacobson and Truax method deter-
mines whether there is individual change in function-
ing relative to a comparison group after treatment.
Although in many cases researchers compute propor-
tions of clients who improved, recovered, remained
unchanged or deteriorated, or even conduct tests
(e.g., chi-square goodness of fit test) comparing the
proportions in each category, this procedure does
not directly compare the treated group to a nor-
mal comparison group. Furthermore, the method
assumes normal distributions when establishing cut-
off points and the RCI. In their paper, Jacobson and
Truax concede that such an assumption is a problem
that limits the generalizability of their method, espe-
cially given decades of research demonstrating that
parametric tests of the form of the RCI are not robust
to violations of the assumption of normality (e.g.,
Cressie & Whitford, 1986) and that cutoffs relative
to distributions that are not normal can be very
misleading.
Clinical Significance using Normative
Comparisons
A more recent approach that addresses the practical
issue of whether the client returns to normal func-
tioning after treatment is the normative comparisons
method. In this approach, clinical significance is
conceptually defined as end-state functioning that
falls within a normative range on important mea-
sures (Kendall, Marrs-Garcia, Nath, & Sheldrick,
1999). In order to determine whether the treated
group falls within a normative range, Kendall et al.
(1999) suggest using a two-independent-samples test
of equivalence (Schuirmann, 1987) on the normative
and treated populations. As Kendall et al. (1999)
mention, when using traditional hypothesis testing to
demonstrate equivalence between groups, the invest-
igator attempts to confirm rather than reject the null
hypothesis of no population mean difference. In
other words, if a researcher is interested in demon-
strating that two groups are equivalent, it would be
inappropriate to use a traditional difference-based
test (e.g., traditional t or F test) because the goal
would be to not reject the null hypothesis that the
population means are equivalent. The first step of
the normative comparison method requires a range
to be established whereby the treated and the
comparison group will be considered equivalent
(−δ, δ). In the second step, one-sided t tests are
conducted on two null hypotheses, H01 and H02,
where:
H01: m1  m2  d; H02: m1  m2  d
H11: m1  m2 < d; H12: m1  m2 > d
H1 represents the alternate hypothesis, µ repre-
sents the population mean, and δ represents the
smallest difference between the groups that would be
considered nontrivial. A significant result for both
tests would result in the researcher concluding that
the difference between the means lies within the
predefined range and that the treated sample is
clinically equivalent to the normative sample (Kendall
et al., 1999).
An issue with this approach is that it is a paramet-
ric statistical test that assumes that the population
variances are equal and the population distributions
are normal in form. It is well known, however, that
sample sizes and variances of the normative and
clinical groups are regularly very disparate (Cribbie
& Arpin-Cribbie, 2009). Furthermore, as Gruman,
Cribbie, and Arpin-Cribbie (2007) show, empirical
Type I error rates for Schuirmann’s test of equival-
ence have been found to deviate substantially from
the nominal α level when sample sizes and variances
are unequal. The implications of these findings are
that researchers may mistakenly declare populations
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equivalent or may mistakenly declare populations
not equivalent. Kendall et al. (1999) were aware
of this limitation; however, they failed to account
for it as their approach uses the original Schuirmann
procedure.
An Equivalence Test that is Robust to
Heterogeneous Variances and Non-Normality
To account for the regularly occurring violations of
the homogeneity of variance assumption, Gruman
et al. (2007) expanded on Schuirmann’s (1987)
original equivalence testing approach by integrating
Welch’s (1938) heteroscedastic standard error and
degrees of freedom into the original model. This
modification deals with the sample size and variance
inequality issues that affect the Schuirmann test of
equivalence (which utilizes the same standard error
and degrees of freedom as the independent-samples
t test).
Gruman et al. (2007) found that Type I error rates
for the Schuirmann-Welch test are maintained at
approximately α even when sample sizes and var-
iances are extremely unequal. There is also very little
power lost by using the Schuirmann-Welch proced-
ure instead of the original Schuirmann equivalence
testing procedure when sample sizes and variances
are equal (Cribbie & Arpin-Cribbie, 2009). There-
fore, due to its robustness when the sample var-
iances are heterogeneous, it was recommended that
researchers evaluating clinical significance via equi-
valence testing routinely utilize the Schuirmann-
Welch procedure.
Although the Schuirmann-Welch procedure
addresses the heterogeneity of variance issue, there
still are limitations in its application in normative
comparisons. Classic parametric methods, such as
the Schuirmann-Welch procedure, assume that the
data being analyzed are normally distributed. Much
research has been conducted to this end and the
general consensus is that this assumption is rarely
met in real data (Erceg-Hurn & Mirosevich, 2008;
Golinski & Cribbie, 2009). For example, Micceri
(1989) examined 440 large data sets from psycholo-
gical and educational studies and concluded that
none of the data were normally distributed and that
only a few distributions remotely resembled the
normal curve. Furthermore, it is well known that
the usual group means and variances are greatly
influenced by the presence of extreme observations
in score distributions (Keselman, Wilcox, & Lix,
2003). Extreme observations or heavy tails can
significantly increase the standard error of the
mean. Consequently, using measures that are not
robust to non-normality and outliers, according to
Wilcox (1994), can distort the view of how a typical
individual in one group compares to a typical indi-
vidual in another, how well Type I errors are
controlled, and the power of the test. To account
for these problems, a popular approach has been to
remove the atypical values by trimming the data
(Wilcox, 2012). Although a wide range of robust
estimators have been proposed in the literature,
the trimmed mean and Winsorized variance, which
are calculated by removing extreme observations,
have been most appealing (Keselman et al., 2003;
Wilcox, 1994, 2012). As Wilcox (2012) and Keselman,
Othman, Wilcox, and Fradette (2004) establish, the
Type I error rates and power to detect effects are
much less affected by extremities and non-normality
when trimmed means are substituted for the usual
means and variances. In conjunction with trimmed
means and Winsorized variances, Yuen (1974) sug-
gested that Welch’s (1938) statistic be used. In her
study, Yuen found that the statistic based on trimmed
means and Winsorized variances could adequately
control the rate of Type I errors and resulted in
greater power than a statistic based on the usual
mean and variance for heavily tailed distributions
(Keselman et al., 2003).
The Current Study
van Wieringen and Cribbie (in press) used the
Schuirmann-Yuen method and compared its effec-
tiveness to the Schuirmann and Schuirmann-Welch
tests of equivalence using a series of Monte Carlo
simulations with different distribution shapes, sample
standard deviations, and sample sizes. Their results
indicate that when two groups with non-normal (and
potentially different) distribution shapes are being
compared, the empirical Type I error control of the
Schuirmann-Yuen is substantially better than that of
the original Schuirmann or the Schuirmann-Welch.
The power rates also differed between these tests,
with rates generally 10% to 30% higher for the
Schuirmann-Yuen than for the Schuirmann or
Schuirmann-Welch procedures for non-normal dis-
tributions. For example, they reported that when
sample sizes were large and one distribution was
skewed and one distribution contained outliers in
one tail, that power was recorded at .204, .293, and
.509 for the Schuirmann, the Schuirmann-Welch,
and the Schuirmann-Yuen, respectively. While the
effectiveness of the Schuirmann-Yuen under condi-
tions that violate the assumptions of homogeneity of
variance and normal distributions has been pre-
viously established, the present study attempts to
extend its application to real data gathered from a
sample of published studies that examined interven-
tions for depression. This extension doubly augments
current literature and further allows one to capture
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why these robust measures of clinical significance are
so valuable when attempting to discern the thera-
peutic value of interventions. Firstly, given the pos-
sibility for disparate conclusions to arise when
assessing clinical significance as opposed to statistical
significance, the value of evaluating this possibility
using data from previously published studies is
pronounced since differing conclusions could impact
whether a given intervention is purported to be
efficacious or not. Secondly, using real data allows
us to screen for violations of parametric assumptions
to determine whether factors such as non-normality
or variance heterogeneity could contribute to any
different findings when comparing conclusions on
the efficacy of treatments using Schuirmann-Yuen,
Schuirmann-Welch, and Schuirmann tests of equi-
valence. The focus of this study, therefore, is to
demonstrate the analytical and practical power of
robust normative comparison methods for making
statements regarding the efficacy of therapies for
depression.
Method
In order to quantify clinical significance with the
Schuirmann-Yuen normative comparison method,
we collected a sample of published studies that tested
the effectiveness of interventions for depression.
Although there are a number of different alternatives
that could have been considered, depression was
selected because of its prevalence and the fact that a
vast amount of research has been published on the
effectiveness of existing therapies (e.g., Driessen
et al., 2007; Gaynor et al., 2003; Nasiakos, Cribbie,
& Arpin-Cribbie, 2010). It is important to point out
though, as highlighted by a reviewer of the paper, that
different depression scales are sensitive to different
forms, symptoms, and severities of depression and
therefore caution is needed in interpreting the results.
Collection of Past Studies
A specific set of search criteria was used in PsycINFO
to collect studies of potential interest: “Effective-
ness,” “efficacy,” “effect,” or “evaluation” in the
document title, “intervention,” “therapy,” or “treat-
ment” in the document title, “depression” in the
document title, and “psychotherapy,” “cognitive
therapy,” or “behavioral therapy” in any other field.
These search criteria were used in an effort to identify
studies that evaluated the effectiveness of interven-
tions for depression. The date range of our search
was restricted from 2000 to 2011 to ensure that the
data we gathered from the studies were current. Of
the original studies found, an inclusion criterion for
further consideration was the availability of pre- and
post-treatment data for clinical groups on indicators
of depressive symptomatology. The principal investi-
gators of studies that met these criteria were then sent
a request, by e-mail, for access to the raw data from
the intervention study. It is important to highlight
that the Schuirmann-Yuen cannot be computed with
summary descriptive information (e.g., means and
standard deviations), and thus in order to compute
the procedure we needed to collect raw data. A total
of 99 authors were contacted, 40 of whom initially
responded. Only two of these authors, however,
provided us with their datasets and assented to using
them for our analyses. A follow-up email was then
sent to the 59 authors who had not responded,
yielding four more pertinent datasets. A summary of
each of the corresponding studies for the six datasets
is provided in Table I.
Normative Comparison Data
Normative data were gathered for the outcome
measures utilized in the published studies we col-
lected. As Nasiakos et al. (2010) mention, in order
to determine clinical significance, treatment groups
Table I. Description of the intervention studies.
Study Description
Goldman et al. (2006) The effectiveness of client-centered therapy was compared to emotion-focused therapy in treating depressive
symptoms. Pre-post measures were taken using the BDI.
Topolovec-Vranic
et al. (2010)
The effectiveness of an internet-based cognitive behavior program (Mood GYM) in treating depressive symptoms
in clients with a traumatic brain injury was evaluated. Pre-post measures were taken using the CES-D.
Henkel et al. (2010) This study examines the efficacy of sertraline and cognitive behavioral therapy (CBT) among depressed patients
with atypical features. Pre-post measures were taken using the IDS and HAM-D.
Stice et al. (2010) High-risk adolescents with elevated depressive symptoms were randomized to a brief group cognitive-behavioral
(CB) intervention, group supportive-expressive intervention, bibliotherapy, or assessment-only control
conditions. Pre-post measures were taken using the BDI.
Mohr et al. (2005) This study tested the efficacy of a 16-week telephone-administered cognitive-behavioral therapy (T-CBT) against
a strong control for attention and nonspecific therapy effects.
Koch et al. (2007) The study investigated the specific effects of a dance intervention on the decrease of depression symptoms. Pre-
post measures were taken using the HBS.
242 H. Mangardich and R. A. Cribbie
must be compared with a normative group and for a
most appropriate comparison, it is advised that
either representative normative data be collected
by the researchers or that normative data matching
important characteristics of the sample be gleaned
from published sources (Kendall & Sheldrick, 2000).
Kendall and Sheldrick list a set of studies for different
outcome measures for depression and note that if
any of the identified outcome measures in their
paper are analyzed in a given treatment outcome
study, the respective sources of normative data can
be found in their paper and be directly applied in
normative comparisons. For our purposes, it would
be impractical to collect normative data that matched
the sample characteristics of the different treatment
groups in each of the six datasets (e.g., traumatic
brain injury patients). Furthermore, it was necessary
for our analyses to collect complete normative data
(i.e., not just means, standard deviations, sample
sizes, etc. that are reported in most papers and in
review articles such as Kendall and Sheldrick), as we
needed the individual scores for each participant
on the outcome measures in order to compute the
trimmed means and Winsorized variances. Normat-
ive data were gathered from a sample of 184 under-
graduate university students (29.9% male) aged 17
to 33 years old (mean age was 19.5). These partici-
pants were enrolled in introductory psychology
courses and took part in the study in exchange for
class credit. The sample varied vastly in self-
identified race/ethnicity, being composed of 36%
white, 7% black, 15% East and/or South-East Asian,
4% Hispanic, 11% Middle Eastern, 22% South
Asian and 5% mixed. Although we freely acknow-
ledge that our normative sample is not a perfect
match to each of the populations in the empirical
studies obtained, as demonstrated below our norm-
ative sample was found to be equivalent to published
general population normative data and thus we
believe that our comparisons are meaningful.
Statistical Analyses
The Schuirmann-Yuen (van Wieringen & Cribbie,
in press), Schuirmann-Welch, and Schuirmann
(Cribbie & Arpin-Cribbie, 2009) equivalence tests
for normative comparisons were modeled with the R
statistical software application (R Foundation for
Statistical Computing, 2011). For our normative
comparison analyses, we defined δ in the equivalence
interval (δ, δ) as one standard deviation of the
normative mean. Although this value was somewhat
arbitrarily selected, one standard deviation has been
used in the past in normative comparison examples
(e.g., Kendall et al., 1999). We also included
comparisons to the traditional paired-samples t-tests
comparing pre- and post-test scores and an analysis
using the Jacobson and Truax (1991) method for
assessing clinical significance.
Results
All of the empirical studies tested the effectiveness of
therapies for depression. Some, however, included
multiple groups, tested the effectiveness of multiple
therapies, and had multiple outcome variables. For
the purposes of our study, we used the post-test data
for all non-control groups on the outcome measure
of depression. Therefore, a total of 18 clinical
samples were included in our analyses.
Normative Data
Table II presents a summary of the normative data
we gathered in order to conduct the normative
comparisons. Normative data were collected for the
five measures of depression used in the six studies
(the order of appearance was randomized when
participants completed the scales): Center for
Epidemiological Studies – Depression Scale (CES-
D), Inventory of Depressive Symptomatology (IDS),
Hamilton Depression Scale (HAM-D), Heidelberger
Befindlichkeitsskala (HBS), and the Beck Depres-
sion Inventory (BDI). Table II also presents pub-
lished normative data for these depression measures
for comparison purposes (although we were not able
to locate published normative data for the HBS). It
is important to note that the psychometric properties
(e.g., reliability, validity) differ across the set of
outcome measures that were used. Five different
Schuirmann-Welch equivalence tests showed that the
scores on the outcome measures of depression for
our sample of undergraduate students were equiva‐
lent to those found in sources of normative data
from previously published studies (Campo-Arias,
Diaz-Martinez, Rueda-Jaimes, Cadena-Afanador, &
Her-nandez, 2007; Crawford, Cayley, Lovibond,
Wilson, & Hartley, 2011; Gonzalez, Boals, Jenkins,
Schuler, & Taylor, 2013).
Table II. Summary of the normative data used in the normative
comparison analyses (N = 184) and published normative data.
Normative data from this study
Published
normative data
Scale M SD Shapiro-Wilk p M SD
CES-D 15.66 10.37 .000 17.16 9.88
IDS 15.99 12.35 .000 15.03 11.18
HAM-D 7.88 7.17 .000 6.25 4.24
BDI 9.58 8.75 .000 6.25 6.94
HBS 3.31 1.96 .000 N/A N/A
Note. N/A indicates that the data were not available.
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Normality and Variance Homogeneity
Assumptions
Regarding the assumption of normality within our
normative data, all of the distributions of the
outcome measures were non-normal (all ps < .001),
using the Shapiro-Wilk test of normality (Table II).
Table III presents the clinical measures of depres-
sion used within each study and also provides the
pre- and post-test descriptive data for each clinical
group. Specifically, the table provides pre- and post-
test sample sizes, means and standard deviations. Of
the 18 clinical groups, four pre-treatment distribu-
tions and 10 post-test distributions were determined
to be non-normal using the Shapiro-Wilk test, with
all being extremely skewed. Bartlett’s test of homo-
geneity of variance was conducted to compare the
variances of the normative and post-test clinical
groups, and of the 18 comparisons six had hetero-
geneous variances (see Table IV). It is also import-
ant to highlight that the sample sizes (N = 10 to
N = 89) in these studies were small to moderate, and
thus statistically significant tests of normality and
Table III. Summary of the depression intervention studies obtained for analysis.
Study
Primary
outcome Intervention groups
Pre –
Post N Pre – Post M Pre – Post SD
Goldman et al. (2006) BDI Process-experiential 36 – 36 26.11 – 6.17 6.96 – 5.33
Client-centered 36 – 36 24.56 – 9.53 6.54 – 7.48
Topolovec-Vranic
et al. (2010)
CES-D Online cognitive behavioral therapy
program
13 – 13 30.69 – 23.38 8.24 – 11.24
Henkel et al. (2010) HAM-D Sertraline 22 – 22 17.18 – 11.59 4.25 – 8.14
CBT 22 – 22 16.50 – 11.23 4.11 – 6.39
GSG 26 – 26 14.46 – 14.15 3.82 – 5.72
IDS Sertraline 22 – 22 28.55 – 18.27 7.61 – 13.05
CBT 22 – 22 27.41 – 18.18 5.79 – 10.42
GSG 26 – 26 24.50 – 23.00 6.15 – 10.67
Stice et al. (2008) BDI CB intervention 89 – 86 20.24 – 10.89 10.41 – 9.17
Group supportive-expressive intervention 88 – 83 20.23 – 14.54 9.84 – 10.74
Bibliotherapy 80 – 74 17.92 – 14.38 7.14 – 9.00
Mohr et al. (2005) BDI Experiential 62 – 62 27.39 – 18.48 7.06 – 10.28
CBT 60 – 60 27.87 – 15.00 8.71 – 10.84
HAM-D Experiential 62 – 62 21.44 – 14.52 3.63 – 6.88
CBT 60 – 60 21.45 – 12.28 3.77 – 5.73
Koch et al. (2007) HBS Dance-only 11 – 11 5.18 – 6.41 1.40 – 1.20
Music-only 10 – 10 6.25 – 6.00 1.83 – 2.40
Note. CBT = cognitive behavioral therapy; GSG = guided self-help group.
Table IV. Summary of the variance homogeneity and normal distribution assumptions.
Study
Primary
outcome Intervention groups Bartlett’s p Pre – Post Shapiro-Wilk p
Goldman et al. (2006) BDI Process-experiential 0.0007328 .008 – .005
Client-centered 0.2462 .205 – .002
Topolovec-Vranic et al. (2010) CES-D Online cognitive behavioral therapy
program
0.6954 .529 – .097
Henkel et al. (2010) HAM-D Sertraline 0.4234 .474 – .217
CBT 0.4958 .150 – .171
GSG 0.1586 .580 – .489
IDS Sertraline 0.733 .342 – .212
CBT 0.3535 .645 – .606
GSG 0.05627 .913 – .861
Stice et al. (2008) BDI CB intervention 0.6536 .014 – .000
Group supportive-expressive intervention 0.02681 .389 – .001
Bibliotherapy 0.7345 .612 – .019
Mohr et al. (2005) BDI Experiential 0.1185 .148 – .044
CBT 0.03844 .001 – .013
HAM-D Experiential 0.6957 .146 – .261
CBT 0.04303 .243 – .007
Koch et al. (2007) HBS Dance-only 0.06813 .092 – .436
Music-only 0.374 .349 – .063
Note. CBT = cognitive behavioral therapy; GSG = guided self-help group.
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variance heterogeneity are unlikely to be due to
inflated sample sizes. Further, and more likely, is
that the non-significant tests were due to low power
for detecting assumption violations.
Clinical Significance Tests
Before presenting the results of the normative
comparisons, we first provide results using a tradi-
tional paired t-test to compare the pre- and post-test
Table V. Summary of the equivalence-based clinical significance analyses, pre-post differences, and pre-normative differences for the
intervention studies.
Normative comparison
Study
Primary
outcome Intervention groups
Schuirmann and
Schuirmann-Welch
Schuirmann-
Yuen
ΔPre-post
p < .05 η2pre-post
ΔPre-
normative p
< .05
Goldman
et al. (2006)
BDI Process-experiential E E Yes 0.85 Yes
Client-centered E E Yes 0.80 Yes
Topolovec-
Vranic
et al. (2010)
CES-D Online CBT NE NE Yes 0.31 Yes
Henkel
et al. (2010)
HAM-D Sertraline E NE Yes 0.33 Yes
CBT E E Yes 0.33 Yes
GSG NE NE No 0.003 Yes
IDS Sertraline E E Yes 0.40 Yes
CBT E E Yes 0.44 Yes
GSG E NE No 0.02 Yes
Stice et al. (2008) BDI CBT E E Yes 0.40 Yes
Group supportive-
expressive intervention
E E Yes 0.27 Yes
Bibliotherapy E E Yes 0.18 Yes
Mohr et al. (2005) BDI Experiential NE NE Yes 0.30 Yes
CBT E E Yes 0.44 Yes
HAM-D Experiential NE NE Yes 0.45 Yes
CBT E E Yes 0.67 Yes
Koch et al. (2007) HBS Dance-only NE NE Yes 0.71 Yes
Music-only NE NE No 0.07 No
Note. CBT = cognitive behavioral therapy; GSG = guided self-help group; E = equivalent; NE = not equivalent.
Table VI. Summary of the Jacobson and Truax (1991) clinical significance analyses.
Study Primary outcome Intervention groups Percentage of individuals recovered
Goldman et al. (2006) BDI Process-experiential 86%
Client-centered 56%
Topolovec-Vranic et al. (2010) CES-D Online cognitive behavioral therapy program 8%
Henkel et al. (2010) HAM-D Sertraline 50%
CBT 36%
GSG 14%
IDS Sertraline 27%
CBT 23%
GSG 4%
Stice et al. (2008) BDI CB intervention 31%
Group supportive-expressive intervention 17%
Bibliotherapy 9%
Mohr et al. (2005) BDI Experiential 39%
CBT 45%
HAM-D Experiential 45%
CBT 65%
Koch et al. (2007) HBS Dance-only N/A
Music-only N/A
Note. CBT = cognitive behavioral therapy; GSG = guided self-help group; N/A indicates that we were unable to calculate this. This is due to
a lack of test-retest reliability for the HBS.
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means and also the results using the Jabobson and
Truax (1991) method to determine the proportion of
clients who reliably improved and moved beyond
two standard deviations from the clinical mean (see
Tables V and VI). The paired t results indicated that
15 clinical samples showed statistically significant
improvement from pre-test to post-test, although we
caution the reader that these tests were simple paired
comparisons that were not in reference to a control
group and did not control for any other variables.
Eta squared was also calculated for each of the pre-
test to post-test differences as a measure of effect
size. The results of the Jacobson and Truax (1991)
analyses indicated that there was substantial variab-
ility in the percentages of clients who reliably
improved and moved outside the range of the
clinical population.
Table V summarizes the results from the normat-
ive comparisons using the Schuirmann, Schuir-
mann-Welch, and Schuirmann-Yuen equivalence
tests. As outlined by Cribbie and Aprin-Cribbie
(2009), the first step of their normative comparison
method requires comparing the pre-test and norm-
ative means. This comparison was conducted using
the heteroscedastic trimmed Welch procedure
(Yuen, 1974) since the distributions were often not
normal and the variances often differed substantially.
As expected, all of the 18 clinical samples had pre-
test means that differed significantly from the norm-
ative means (see Table V). The normative compar-
ison results for the 18 clinical samples show that 12
exhibited equivalence to the normal comparison
group using both the Schuirmann and Schuirmann-
Welch methods at ± 1.0 SD interval. These results
differed from normative comparisons using the
Schuirmann-Yuen method (at the same equivalence
interval), where only 10 clinical samples were con-
sidered equivalent and so represented clinically
significant change. Although the normative compar-
ison, paired t, and Jacobson and Truax results were
definitely related (e.g., for those declared equivalent
to the normal comparison group the average per-
centage of clients meeting Jacobson and Truax
criteria was 40%, and for those not declared equi-
valent to the normal comparison group the average
percentage was 27%), they also provide distinct
information about the clinical significance of the
treatment effects.
Discussion
Measures of clinically significant improvement for
groups of patients influence the degree to which
treatments are generally considered to be effective or
in need of modification (Bauer et al., 2004). Because
of the increasing value psychologists place on
evidence-based therapeutic methods (e.g., Norcross,
Beutler, & Levant, 2005), there have been many
methods proposed to assess clinical significance. A
recent approach that has become the recommended
method for assessing group-level clinical significance
is Kendall et al.’s (1999) normative comparison
method that uses the Schuirmann (1987) test of
equivalence. Two important issues with the method,
however, are that it assumes normal distributions
and homogeneity of variances between the clinical
and normative groups. Ignoring these assumptions
and utilizing tests that are not robust to these
assumptions can result in empirical conclusions
that are inaccurate; depending on the nature of the
distributions populations can mistakenly be declared
equivalent or not equivalent. In this study, consistent
with past research (e.g., Micceri, 1989), most of the
clinical samples (61%) had non-normal distributions
at post-test and none of the normative distributions
were normally distributed (more specifically, they
were all extremely skewed). Six of the 18 clinical
samples also had variances significantly different
from the normative sample. Given that van Wierin-
gen and Cribbie (in press) found that only the
Schuirmann-Yuen was robust to simultaneous viola-
tions of the normality and variance homogeneity
assumptions, these results definitely provide support
for the recommendation that researchers should
always use the Schuirmann-Yuen test for normative
comparisons.
This study extended the findings of van Wieringen
and Cribbie (in press) to real data in order to provide
information about the clinical significance of the
interventions and also to test whether differences in
the conclusions would be found when using the
Schuirmann-Yuen test compared to the Schuirmann
and Schuirmann-Welch tests. We found that, of the
18 clinical samples, the Schuirmann-Yuen test
determined equivalence for about 11% fewer clinical
samples than the Schuirmann and Schuirmann-
Welch tests with an equivalence interval of ± 1.0 SD.
The value of these intervention studies lies in their
ability to accurately distinguish therapies that are
efficacious for the everyday functioning of the client.
Even though only a handful of clinical samples were
analyzed, the results of van Wieringen and Cribbie
and the current study highlight the importance of
using an appropriate test statistic, one that over-
comes violations of parametric assumptions in order
to ensure that the conclusions are accurate.
The results of this study also illustrate why deter-
mining clinical significance has important implications
when considering which intervention to use. For
example, 15 of the 18 clinical samples had statistically
significant changes from pre- to post-test, whereas
normative comparisons using a Schuirmann-Yuen
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test determined equivalency for 10 clinical samples
(however, it is important to highlight again that these
analyses were conducted with paired-samples t-tests
and did not include the control groups, covariates or
other predictors that may have been present in the
full models analyzed in the published papers).
Therefore, although a given intervention may ren-
der a statistically significant difference from pre- to
post-test data for the treatment group, the interven-
tion does not necessarily return the group to a state
of normal functioning. As Nasiakos et al. (2010)
mention, methods that determine clinical signific-
ance, such as normative comparisons, provide
supplementary information regarding whether the
treated group returned to a state of “normal”
functioning, a common goal of intervention studies
for depression. By conducting robust normative
comparisons on real data, this study demonstrates
that different conclusions indeed do arise when
clinical significance tests are conducted as opposed
to statistical significance tests.
Although the findings of this study are important
for showing the value of applying robust measures of
clinical significance, there are a couple of limitations
of the current research to consider. Firstly, interven-
tion studies for depression were chosen for conduct-
ing our robust clinical significance analyses,
therefore it is unclear how our results would com-
pare to results of the analyses when applied to other
outcomes such as anxiety. Furthermore, we were
only able to gather a handful of the numerous
published intervention studies for depression so the
conclusions of this study may not necessarily extend
to the population of studies. However, the results of
this study mirror previous quantitative studies, as
discussed above, that have highlighted that distribu-
tions are often non-normal, population variances are
often not equal, and that tests based on robust
estimators outperform tests based on standard esti-
mators such as the usual mean and variance. Lastly,
the results of this paper were summarized across
different measures of depression that may deviate in
the extent to which they are appropriate for under-
graduate students (i.e., our normal comparison
group). Although we have shown that the central
tendencies of the undergraduate and general popula-
tions are equivalent, the differences that remain
could be meaningful.
To conclude, this study collected data from
published intervention studies that tested the effec-
tiveness of therapies for depression and analyzed the
data using the Schuirmann, Schuirmann-Welch, and
Schuirmann-Yuen equivalence-based normative
comparison methods. We found that most clinical
samples had violations of the homogeneity of vari-
ance and/or normality assumptions, and therefore we
recommend that researchers conducting normative
comparisons utilize the Schuirmann-Yuen proced-
ure as it provides the most reliable method available
for determining whether a treated clinical group is
equivalent to a normative comparison group. An R
(The R foundation for Statistical Computing, 2011)
function for conducting the normative comparison
tests discussed in this article is available at http://
www.psych.yorku.ca/cribbie.
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